Here's Why Investors Must Hold IQV Stock in Their Portfolios for Now
IQVIA's record $34.2B backlog, AI-led pharma demand and $1.24B buybacks support growth despite weak liquidity and no dividend.
Open original sourceLoading market dashboard
IQVIA's record $34.2B backlog, AI-led pharma demand and $1.24B buybacks support growth despite weak liquidity and no dividend.
Open original source